Nuo Therapeutics Inc. (AURX)
OTC
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
1.2952 wk Range
0.7700Overview - AURX - Nuo Therapeutics Inc.
Key Statistics
Valuation
Enterprise Value
64.32M
P/E (Trailing)
-25.99
P/E (Forward)
-131.00
PEG Ratio
0.51
Price / Sales (TTM)
12.20
Price / Book
-40.98
EV / EBITDA
-39.29
Profitability
Gross Margin
66.14%
Profit Margin
-38.70%
Operating Margin
-9.41%
Return on Assets
-54.33%
Return on Equity
262.63%
Ownership
Shares Outstanding
48.40M
Float
20.29M
Held by Insiders
57.89%
Held by Institutions
0.01%
Price stats
Beta
-881.24
50-Day Avg
1.15
200-Day Avg
1.28
Dividends
Payout Ratio
0.00%
Analyst Consensus
1 analysts
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AURX - Nuo Therapeutics Inc.
Peers - AURX - Nuo Therapeutics Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
- AURXOTCNuo Therapeutics Inc.62.96MMarket Cap-92.18%52-week change-26.00P/E (Trailing)-38.70%Profit Margin
- ARGNFOTCargenx SE49.68BMarket Cap-5.49%52-week change30.11P/E (Trailing)32.26%Profit Margin
- BEIGFOTCBeiGene Ltd.32.45BMarket Cap+27.32%52-week change51.04P/E (Trailing)10.69%Profit Margin
- AAVXFOTCAbivax SA12.13BMarket Cap+32.88%52-week change-28.78P/E (Trailing)0.00%Profit Margin
- AKESFOTCAkeso Inc.10.36BMarket Cap-39.80%52-week change25.67P/E (Trailing)-28.03%Profit Margin
- AKBLFOTCALK-Abelló A/S8.08BMarket Cap+11.37%52-week change38.42P/E (Trailing)19.85%Profit Margin
- BCHMYOTCBachem Holding AG7.59BMarket Cap+29.29%52-week change40.56P/E (Trailing)21.02%Profit Margin
Profile Summary - AURX - Nuo Therapeutics Inc.
About
Nuo Therapeutics Inc. is a biotechnology company primarily engaged in developing regenerative therapies for wound care. The company's flagship product, Aurix, is an advanced platelet-rich plasma therapy designed to enhance the body's natural healing response, particularly in treating chronic wounds like diabetic…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
